Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AltheaDx employs Wendy Benson as CEO

This article was originally published in Clinica

Executive Summary

Molecular diagnostics firm AltheaDx has appointed Wendy Benson to the position of CEO and president. She will replace interim co-CEOs, Dr François Ferré and Dr Magda Marquet, who will remain at the firm as co-chairs on the company’s board. Ms Benson was recently president and CEO at infectious disease specialist HX Diagnostics and has previously worked at Roche Molecular Diagnostics, Ortho Clinical Diagnostics and Genetic Systems. Ms Benson will also join AltheaDx’s board of directors along with Ann Kessler, former director of international project management at Hoffman-La Roche. Dr Kessler joins the firm as an independent director.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094663

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel